ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery
2020 · Biomedicine & Pharmacotherapy · 79 citations
https://doi.org/10.1016/j.biopha.2020.110835
Y
Yubo Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
340
Papers
5.2K
Citations
37
h-index
154
i10-index
Yubo Li is an academic researcher from Capital Medical University. The author has contributed to research in topics: Metabolomics and Mass Spectrometry Studies & Traditional Chinese Medicine Analysis & Natural product bioactivities and synthesis. The author has an h-index of 37, co-authored 289 publications.
ORCID: 0000-0003-0455-0969Papers by this author
worksA strategy for the discovery and validation of toxicity quality marker of Chinese medicine based on network toxicology
2018 · Phytomedicine · 48 citations
https://doi.org/10.1016/j.phymed.2018.01.018
Effects of stress on behavior and resting-state fMRI in rats and evaluation of Telmisartan therapy in a stress-induced depression model
2018 · BMC Psychiatry · 46 citations
https://doi.org/10.1186/s12888-018-1880-y
Safety Research in Traditional Chinese Medicine: Methods, Applications, and Outlook
2019 · Engineering · 39 citations
https://doi.org/10.1016/j.eng.2018.11.019
Efficient selective removal of uremic toxin precursor by olefin-linked covalent organic frameworks for nephropathy treatment
2023 · Nature Communications · 37 citations
https://doi.org/10.1038/s41467-023-38427-3
A Novel and Practical Chromatographic “Fingerprint-ROC-SVM” Strategy Applied to Quality Analysis of Traditional Chinese Medicine Injections: Using KuDieZi Injection as a Case Study
2017 · Molecules · 35 citations
https://doi.org/10.3390/molecules22071237
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat